E-Mechanic_Fol: Effects of Aerobic Exercise Detraining

Sponsor
Pennington Biomedical Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT02158130
Collaborator
(none)
25
1
18
1.4

Study Details

Study Description

Brief Summary

The proposed study seeks to better understand the role of body weight, energy expenditure, and energy intake as mechanisms of body weight gain during detraining following aerobic exercise. It is hypothesized that participants in the higher dose exercise group will have greater body weight gain compared to the lower exercise dose and control group from wk 24 to wk 76 follow-up.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Eligibility criteria include having successfully completed the main E-Mechanic study, be willing to archive blood samples and not being currently enrolled in another study that may effect body, energy intake or energy expenditure. The investigators will measure body weight, waist/hip circumference, blood pressure, body composition, physical activity, questionnaire about appetite/food intake and physical fitness.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    25 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Effects of Aerobic Exercise Detraining on Energy Balance in Overweight Persons
    Study Start Date :
    Sep 1, 2014
    Actual Primary Completion Date :
    Mar 1, 2016
    Actual Study Completion Date :
    Mar 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Healthy Living

    non exercise healthy living control group

    General Health

    Exercise Group (8 KKW) One exercise group will obtain 8KKW (kcal/kg/week) over 3-4 sessions per week, which will result in each session lasting approximately 30 minutes. We will recruit 1 year post study intervention.

    Weight Loss

    Exercise Group (20 KKW) Exercise group will obtain 20 KKW, perform in 4-5 sessions per week for approximately 50-70 minutes per session. We will recruit 1 year post study intervention.

    Outcome Measures

    Primary Outcome Measures

    1. Body Weight [Week 64 - 88 post study randomization]

      Fasting body weight

    Secondary Outcome Measures

    1. Energy Expenditure [Week 64 - 90 since study randomization]

      Energy expenditure is calculated with the Sensewear Armband.

    2. Energy Intake [Week 64 - 90 post study randomization]

      Energy expenditure is calculated with the Sensewear Armband and furthermore, energy intake is calculated by adjusting TDEE for change in body weight following the methods used in doubly labeled water adjustment.

    Other Outcome Measures

    1. Circumferences [Week 64-88 post study randomization]

      Waist and hip circumferences

    2. Blood Pressure [Week 64-88 post study randomization]

    3. Body Composition [Week 64 - 88 post study randomization]

      Whole Body Scan GE iDXA (Dual energy x-ray absorptiometry)

    4. Triglycerides [Week 64 - 88 post study randomization]

    5. Cholesterol [Week 64 - 88 post study randomization]

      Total, HDL, and LDL cholesterol

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 67 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Completed the E-Mechanic study

    • Be willing to archive blood samples

    • Not participating in a study that would alter body weight, energy intake, or energy expenditure.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pennington Biomedical Research Center Baton Rouge Louisiana United States 70808

    Sponsors and Collaborators

    • Pennington Biomedical Research Center

    Investigators

    • Principal Investigator: John W Apolzan, PhD, PBRC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    John Apolzan, Principal Investigator, Pennington Biomedical Research Center
    ClinicalTrials.gov Identifier:
    NCT02158130
    Other Study ID Numbers:
    • PBRC 2014-028
    First Posted:
    Jun 6, 2014
    Last Update Posted:
    Mar 22, 2016
    Last Verified:
    Mar 1, 2016
    Keywords provided by John Apolzan, Principal Investigator, Pennington Biomedical Research Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 22, 2016